What valuation are you expecting given the results Anavex have produced to date from 3 potentially pivotal, but strictly failed clinical trials?
Keep in mind that the analyst valuations are looking 12 months ahead with assumptions of approvals and revenue ahead - a scenario that may happen with some non zero chance later than 12 months from now.